Blend Labs (NYSE:BLND) Receives Buy Rating from Canaccord Genuity Group

Market Beat
2025.08.24 12:32
portai
I'm PortAI, I can summarize articles.

Canaccord Genuity Group has reaffirmed a "buy" rating for Blend Labs (NYSE:BLND) with a target price of $5.25, indicating a potential upside of 51.08%. Other analysts have varied opinions, with Goldman Sachs lowering their target to $4.80 and UBS to $3.50. Blend Labs' stock opened at $3.4750, with a market cap of $902.32 million. The company reported a quarterly loss of $0.03 per share, missing estimates. Insider trading activity has seen significant share sales recently, and institutional investors have been adjusting their holdings in the company.